NEW YORK (GenomeWeb News) – The National Institutes of Health will fund research into biomedical informatics and computational biology through three new programs, including two small business-focused grants.
The grants will support an R01 program, a Small Business Innovation Research program, and a Small Business Technology Transfer program. The research, with funding from a number of NIH institutes, including the National Human Genome Research Institute, will go to a wide range of bioinformatics approaches and areas of exploration including those used in genomics, genetics, cell biology, medical genetics, and many other fields.
The program, which will be coordinated by the NIH's Biomedical Information Science and Technology Initiative committee, will support studies to develop database design, querying approaches, data visualization and manipulation, integration of analytical tools, tools for electronic collaboration, computational research, and other applications.
The Innovations in Biomedical Computational Science and Technology initiative will fund three grant programs.
An R01 program will grant up to $500,000 for projects that will "span the interface of biomedical research and biomedical computational science and technology," according to NIH.
"Cross-disciplinary collaborations are strongly encouraged, including those which have been initiated or fostered through other cross-cutting initiatives and now are seeking independent support," the institutes advised.
The SBIR program will support biomedical informatics phase I budgets of up to $150,000 per year for two years, and phase II budgets of up to $750,000 per year for three years or less.
This seeks to fund small businesses aiming to conduct research that will support rapid progress in biomedical informatics and computational biology in the same areas as listed in the R01 grants.
The Small Business Technology Transfer grant will support research in the same scientific areas as the SBIR and the RO1 grants. This program will provide budgets of up to $150,000 in costs per year for up to two years for phase I grants and up to $750,000 in total costs per year for up to three years for phase II grants.